The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
Open accessAbstract
Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer. Migration of circulating tumor cells (CTCs) into the blood stream is an early event that occurs during carcinogenesis. We aimed to examine the presence of CTCs in complement to CT-scan in COPD patients without clinically detectable lung cancer as a first step to identify a new marker for early lung cancer diagnosis. The presence of CTCs was examined by an ISET filtration-enrichment technique, for 245 subjects without cancer, including 168 (68.6%) COPD patients, and 77 subjects without COPD (31.4%), including 42 control smokers and 35 non-smoking healthy individuals. CTCs were identified by cytomorphological analysis and characterized by studying their expression of epithelial and mesenchymal markers. COPD patients were monitored annually by low-dose spiral CT. CTCs were detected in 3% of COPD patients (5 out of 168 patients). The annual surveillance of the CTC-positive COPD patients by CT-scan screening detected lung nodules 1 to 4 years after CTC detection, leading to prompt surgical resection and histopathological diagnosis of early-stage lung cancer. Follow-up of the 5 patients by CT-scan and ISET 12 month after surgery showed no tumor recurrence. CTCs detected in COPD patients had a heterogeneous expression of epithelial and mesenchymal markers, which was similar to the corresponding lung tumor phenotype. No CTCs were detected in control smoking and non-smoking healthy individuals. CTCs can be detected in patients with COPD without clinically detectable lung cancer. Monitoring "sentinel" CTC-positive COPD patients may allow early diagnosis of lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
The National Lung Screening Trial: Overview and Study Design
National Lung Screening Trial Research Team (2011) · Radiology · doi:10.1148/radiol.10091808 · Cited by 1,274
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1×
“However, oncogenic KRAS has differing effects – in some cases, it induces hyperproliferation, whereas in others it leads to oncogene induced senescence [43].”
BackgroundDetection, clinical relevance and specific biological properties of disseminating tumour cells
Pantel, K., Brakenhoff, R. H., & Brandt, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2375 · Cited by 1,118
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Paterlini-Brechot, P., & Benali, N. L. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.014 · Cited by 947
Metastasis genes: A progression puzzle
Bernards, R., & Weinberg, R. A. (2002) · Nature · doi:10.1038/418823a · Cited by 798
Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
Chang, Y. S., di Tomaso, E., McDonald, D. M., Jones, R., Jain, R. K., & Munn, L. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14608 · Cited by 671
McGarvey, L. P., John, M., Anderson, J. A., Zvarich, M., & Wise, R. A. (2007) · Thorax · doi:10.1136/thx.2006.072348 · Cited by 561
Molecular insights into cancer invasion: strategies for prevention and intervention.
Kohn, E. C., & Liotta, L. A. (1995) · PubMed · Cited by 496
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Sarkisian, C. J., Keister, B. A., Stairs, D. B., Boxer, R. B., Moody, S. E., & Chodosh, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1567 · Cited by 490
Krebs, M. G., Hou, J.-M., Sloane, R., Lancashire, L., Priest, L., Nonaka, D., Ward, T. H., Backen, A., Clack, G., Hughes, A., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823c5c16 · Cited by 463
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
Kang, Y., & Pantel, K. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.017 · Cited by 421
Mechanistic links between COPD and lung cancer
Houghton, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3477 · Cited by 414
Lecharpentier, A., Vielh, P., Perez-Moreno, P., Planchard, D., Soria, J. C., & Farace, F. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.405 · Cited by 367
Mannino, D. M., Aguayo, S. M., Petty, T. L., & Redd, S. C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.12.1475 · Cited by 349
Wasswa-Kintu, S. (2005) · Thorax · doi:10.1136/thx.2004.037135 · Cited by 324
Considerations in the development of circulating tumor cell technology for clinical use
Parkinson, D. R., Dracopoli, N., Petty, B. G., Compton, C., Cristofanilli, M., Deisseroth, A., Hayes, D. F., Kapke, G., Kumar, P., Lee, J. S., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-138 · Cited by 323
Hofman, V., Bonnetaud, C., Ilie, M. I., Vielh, P., Vignaud, J. M., Fléjou, J. F., Lantuejoul, S., Piaton, E., Mourad, N., Butori, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0445 · Cited by 308
Self-citationLung Cancer in Patients with Chronic Obstructive Pulmonary Disease: Incidence and Predicting Factors
de Torres, J. P., Marín, J. M., Casanova, C., Cote, C., Carrizo, S., Cordoba-Lanus, E., Baz-Dávila, R., Zulueta, J. J., Aguirre-Jaime, A., Saetta, M., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0430oc · Cited by 304
Hofman, V., Ilie, M. I., Long, E., Selva, E., Bonnetaud, C., Molina, T., Vénissac, N., Mouroux, J., Vielh, P., & Hofman, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.25819 · Cited by 304
Self-citationCancer Invasion and Metastasis
Wittekind, C., & Neid, M. (2005) · Oncology · doi:10.1159/000086626 · Cited by 269
Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights
Adcock, I. M., Caramori, G., & Barnes, P. J. (2011) · Respiration · doi:10.1159/000324601 · Cited by 257 · cited 1×
“and is projected to become the fourth leading cause of deaths worldwide by 2030, due to an increase in smoking [8,14].”
BackgroundControversies in clinical cancer dormancy
Uhr, J. W., & Pantel, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106613108 · Cited by 251
Panel of Serum Biomarkers for the Diagnosis of Lung Cancer
Patz, E. F., Campa, M. J., Gottlin, E. B., Kusmartseva, I., Guan, X. R., & Herndon, J. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5392 · Cited by 247
Giuliano, M., Giordano, A., Jackson, S., Hess, K. R., De Giorgi, U., Mego, M., Handy, B. C., Ueno, N. T., Alvarez, R. H., De Laurentiis, M., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2907 · Cited by 217
Parimon, T., Chien, J. W., Bryson, C. L., McDonell, M. B., Udris, E. M., & Au, D. H. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1125oc · Cited by 201
Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer
Lee, G., Walser, T. C., & Dubinett, S. M. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32832c975a · Cited by 179
Mets, O. M., Buckens, C. F. M., Zanen, P., Išgum, I., van Ginneken, B., Prokop, M., Gietema, H. A., Lammers, J. J., Vliegenthart, R., Oudkerk, M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1531 · Cited by 164
Hofman, V., Long-Mira, É., Ilié, M., Bonnetaud, C., Vignaud, J.-M., Fléjou, J., Lantuéjoul, S., Piaton, É., Mourad, N., Butori, C., et al. (2011) · Cytopathology · doi:10.1111/j.1365-2303.2010.00835.x · Cited by 132
Self-citationBlanchon, F., Grivaux, M., Asselain, B. J. R., Lebas, F.-X., Orlando, J.-P., Piquet, J., & Zureik, M. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70868-3 · Cited by 126
Hofman, V., Ilié, M., Bonnetaud, C., Selva, É., Long-Mira, É., Molina, T. J., Vignaud, J.-M., Fléjou, J. F., Lantuéjoul, S., Piaton, É., et al. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcp9x8ozbeiqvvi · Cited by 125
Self-citationEvidence emerges for early metastasis and parallel evolution of primary and metastatic tumors
Gray, J. W. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00167-3 · Cited by 113
Chronic Obstructive Pulmonary Disease with Lung Cancer and/or Cardiovascular Disease
Rodriguez‐Roisin, R., & Soriano, J. B. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200807-075th · Cited by 54
Chronic Obstructive Lung Diseases and Risk of Non-small Cell Lung Cancer in Women
Schwartz, A. G., Cote, M. L., Wenzlaff, A. S., Van Dyke, A., Chen, W., Ruckdeschel, J. C., Gadgeel, S., & Soubani, A. O. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181951cd1 · Cited by 54
A Novel Radiotracer to Image Glycogen Metabolism in Tumors by Positron Emission Tomography
Witney, T. H., Carroll, L. S., Alam, I. S., Chandrashekran, A., Nguyen, Q., Sala, R., Harris, R. A., DeBerardinis, R. J., Agarwal, R., & Aboagye, E. O. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2768 · Cited by 43
A multi-analyte serum test for the detection of non-small cell lung cancer
Farlow, E. C., Vercillo, M. S., Coon, J. S., Basu, S., Kim, A. W., Faber, L. P., Warren, W. H., Bonomi, P., Liptay, M. J., & Borgia, J. A. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605865 · Cited by 41
Current and emerging medical treatments for non–small cell lung cancer: A primer for pulmonologists
Mazzone, P. J., & Mekhail, T. M. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.10.016 · Cited by 19
Cited by
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Alix-Panabières, C., & Pantel, K. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1483 · Cited by 1,394
Progress and prospects of early detection in lung cancer
Blandin Knight, S., Crosbie, P. A., Balata, H., Chudziak, J., Hussell, T., & Dive, C. (2017) · Open Biology · doi:10.1098/rsob.170070 · Cited by 935
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
Lone, S. N., Nisar, S., Masoodi, T., Singh, M., Rizwan, A., Hashem, S., El-Rifai, W., Bedognetti, D., Batra, S. K., Haris, M., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01543-7 · Cited by 819
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
Jolly, M. K. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00155 · Cited by 693
Circulating tumor cell technologies
Ferreira, M. M., Ramani, V. C., & Jeffrey, S. S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.007 · Cited by 511
Metadata
- Authors
- Ilie, M., Hofman, V., Long-Mira, E., Selva, E., Vignaud, J.-M., Padovani, B., Mouroux, J., Marquette, C.-H., & Hofman, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-10-31
- Volume
- 9
- Issue
- 10
- Pages
- e111597
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2090360086
- Cited by
- 415
- References
- 41
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.